https://journals.ku.edu/kjm/article/view/25389/22555
View of Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab: A FAERS...
https://data.cdc.gov/Vaccinations/Monthly-Cumulative-Number-and-Percent-of-Children-/4bdk-kyzv/about_data
Monthly Cumulative Number and Percent of Children 8 Months Who Received Nirsevimab by...
https://pmc.ncbi.nlm.nih.gov/articles/PMC11154801/
Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in...
In September 2023, France was one of the first countries that started a national immunisation campaign with nirsevimab, a new monoclonal antibody against...
respiratory syncytial virusnirsevimabeffectivenesscases
https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/nirsevimab-monoclonal-antibody-rsv-well-tolerated-infants-study
Nirsevimab monoclonal antibody for RSV well tolerated in infants, study suggests | CIDRAP
monoclonal antibody